.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Acorda Company Profile

« Back to Dashboard

Summary for Applicant: Acorda

Patents:6
Tradenames:3
Ingredients:3
NDAs:4
Drug Master File Entries: 0
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acorda
AMPYRA
dalfampridine
TABLET, EXTENDED RELEASE;ORAL022250-001Jan 22, 2010RXYes8,354,437<disabled> <disabled>
Acorda
ZANAFLEX
tizanidine hydrochloride
TABLET;ORAL020397-001Nov 27, 1996RXYes<disabled><disabled>
Acorda
QUTENZA
capsaicin
PATCH;TOPICAL022395-001Nov 16, 2009RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc